FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and concerns treating endothelial-epithelial corneal dystrophy. That is ensured by complex treatment involving local application of taurine and dexpanthenol, systemic introduction of ascorbic acid, thiamine and pyridoxine, as well as introduction of autoplasma under eye conjunctiva in empirically designed mode.
EFFECT: it provides intensification of regeneration and improvement of water-salt metabolism in cornea due to complex action of used medicinal agents.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
| METHOD OF TREATING BULLOUS KERATOPATHY | 2013 |
|
RU2544306C2 |
| METHOD FOR IMPLANTATION OF AHMED ANTIGLAUCOMA DRAINAGE IN NEOVASCULAR ANGLE-CLOSURE GLAUCOMA AND PSEUDOPHAKIA | 2021 |
|
RU2773102C1 |
| METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
| METHOD OF SURGICAL TREATMENT OF ENDOTHELIAL-EPITHELIAL DYSTROPHY OF CORNEA | 2017 |
|
RU2674237C1 |
| METHOD FOR INTRAOPERATIVE FIXATION OF A SUBLUXATED LENS IN PHACOEMULSIFICATION OR LASER EXTRACTION WITH INTRAOCULAR LENS IMPLANTATION | 2019 |
|
RU2699535C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
| METHOD OF TREATING ENDOTHELIAL-EPITHELIAL DYSTROPHY OF THE EYE CORNEA | 2017 |
|
RU2647480C1 |
| METHOD FOR DETERMINING SEVERITY OF CORNEAL ULCER | 2019 |
|
RU2718565C1 |
| METHOD OF TWO-STAGE SURGICAL TREATMENT OF CATARACT IN COMBINATION WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796869C1 |
